Khushbu Patel

5PUBLICATIONS
74CO-AUTHORS
Molecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 05, 2025
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.

Smita Matkar, Michael P East, Timothy J Stuhlmiller

|Jul 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.

Liron D Grossmann, Chia-Hui Chen, Yasin Uzun

|Dec 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.

Amber K Weiner, Alexander B Radaoui, Matthew Tsang

|Aug 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma.

Hai-Feng Zhang, Alberto Delaidelli, Sumreen Javed

|Feb 23, 2021
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models.

Nathan M Kendsersky, Jarrett Lindsay, E Anders Kolb

Pageof 1